Dentists in Trent Woods, NC Accepting Medicare
5 Dentists found. Showing 1 - 5
 Dr. Patrick M Mcdonough, DDS Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 2808 Village Way, Trent Woods, NC 28562 Phone: 252-633-1631 |
Dr. Jim Congleton, D.D.S. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 2811 Village Way, Trent Woods, NC 28562 Phone: 252-633-0424 Fax: 252-638-6662 |
Dr. Jeffery Raymond Thomas, D.D.S. Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 2808 Village Way, Trent Woods, NC 28562 Phone: 252-633-1631 Fax: 252-633-3922 |
Dr. Robert Bryan Harrison, DMD Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 2811 Village Way, Trent Woods, NC 28562 Phone: 252-633-0424 |
Mark William Russell, DMD Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2815 Village Way, Trent Woods, NC 28562 Phone: 252-633-4444 |
News Archive
Combined genomic and proteomic plasma analysis can identify molecular disease mechanisms
For the first time, scientists have combined genomic and proteomic analysis of blood plasma to enhance identification of genetically regulated protein traits. This could be applied to any large association study of civilization diseases where blood plasma has been collected, vastly improving a clinician's ability to identify disease susceptibility in individuals and populations.
MabCure retains CUNY CAT to evaluate monoclonal antibodies against ovarian cancer
MabCure Inc., a leading developer of antibody-based technology for the diagnosis and treatment of ovarian, prostate, colorectal and other cancers, has retained the CUNY Center for Advanced Technology (CUNY CAT) to evaluate its monoclonal antibodies against ovarian cancer cells as diagnostic reagents.
National Journal examines advocates,' lawmakers' efforts to create domestic HIV/AIDS plan
The National Journal on Saturday examined the efforts of some lawmakers and advocates to call for "renewed attention" to the HIV/AIDS epidemic in the U.S., including pushing for a national plan to address the epidemic.
Zymeworks, Merck collaborate to develop novel bi-specific antibody therapeutic candidates
Zymeworks Inc. today announced a research collaboration with Merck, known as MSD outside the United States and Canada, around Zymeworks' proprietary Azymetric platform for the development of novel bi-specific antibody therapeutic candidates. Bi-specific antibodies are designed to bind to two different drug targets for broad use in clinical applications such as oncology or autoimmune disease.
Feds scrutinize Medicaid backlogs in 7 states
Health and Human Services officials have demanded remediation plans from at least seven states - California, Michigan, Tennessee, Missouri, Kansas, Georgia and Alaska - to resolve application backlogs.
› Verified 3 days ago
Dentists
Counselors
Occupational Therapists
Clinical Social Workers
Psychologists